Fatima Zahra Jelloul, MD Associate Professor

Peer-Reviewed Articles

1. Dasdemir, E, Veletic, I, Ly, C, Quesada, AE, Pacheco, CD, Jelloul, FZ, Borges, P, Basu, S, Jindal, S, Wang, Z, Lazar, A, Wani, K, Antunes, DA, Reville, PK, Gunaratne, PH, Tower, RJ, Sharma, P, Abbas, HA. Integrative spatial multi-omics reveal niche-specific inflammatory signaling and differentiation hierarchies in AML. iScience 29(1), 2026. e-Pub 2026.
2. Ly, C, Veletic, I, Pacheco, CD, Dasdemir, E, Jelloul, FZ, Ferri-Borgogno, S, Basi, A, Gomez, JA, Root, J, Reville, PK, Jindal, S, Basu, S, Sharma, P, Quesada, AE, Bueso-Ramos, CE, Manshouri, T, Cuglievan, B, Garcia, MB, Burks, JK, Abbas, HA. Multimodal spatial proteomic profiling in acute myeloid leukemia. npj Precision Oncology 9(1), 2025. e-Pub 2025. PMID: 40394148.
3. Ok, CY, Tang, G, Loghavi, S, Hu, S, Wei, Q, Quesada, AE, Routbort, MJ, Kanagal Shamanna, R, Yin, CC, Sarami, I, Garces, S, Agarwal, N, Luthra, R, Fang, H, Jelloul, FZ, Bryan, J, Medeiros, LJ, Patel, KP, Toruner, GA. Comparative Analysis of Targeted RNA-Seq and Optical Genome Mapping for Detecting Gene Rearrangements in Acute Leukemia. Cancers 17(21), 2025. e-Pub 2025. PMID: 41228256.
4. E, S, Jelloul, FZ, Nahmod, KA, Short, NJ, Leventaki, V, Jia, F, Xu, J, Loghavi, S, Wang, W, Jabbour, LE, Tang, G, Medeiros, LJ, Wang, S. Acute lymphoblastic leukaemia with T- and B-lineage defining markers. Pathology 57(6):739-745, 2025. e-Pub 2025. PMID: 40318961.
5. Sameeta, F, Wang, W, Jelloul, FZ, Nwogbo, OV, Thakral, B, Xu, J, Li, S, Ok, CY, Tang, G, Jia, F, Medeiros, LJ, Loghavi, S, Jorgensen, JL, Wang, SA. The Significance of Detecting an Unusual Myeloblast Immunophenotype in a Presumptive Clinical Diagnosis of Myelodysplastic Syndromes. Archives of Pathology and Laboratory Medicine 149:717-726, 2025. e-Pub 2025. PMID: 39711284.
6. George, GV, Kajstura, M, Jajosky, AN, Fang, H, Jelloul, FZ, Evans, AG, Burack, WR, Bennett, JM, Medeiros, LJ, Wang, W, El Hussein, S. Association Between B-Cell Marker Expression and RUNX1 Lesions in Acute Myeloid Leukemia, Beyond RUNX1::RUNX1T1 Fusion: Diagnostic Pitfalls with Mixed-Phenotype Acute Leukemia—B/Myeloid. Cancers 17(8), 2025. e-Pub 2025. PMID: 40282530.
7. Wang, P, Yang, RK, Jelloul, FZ, Luthra, R, Routbort, MJ, Chen, H, Loghavi, S, Ok, CY, Kanagal Shamanna, R, Roy Chowdhuri, S, Medeiros, LJ, Patel, KP. Routine Clinical Liquid Biopsy Testing for Solid Tumors Delivers the Promise of Minimally Invasive Detection of Genomic Variants With a Faster Turnaround Time. JCO Precision Oncology 9, 2025. e-Pub 2025. PMID: 40138600.
8. Nahmod, KA, Miranda, R, Vega Vazquez, F, Thakral, B, Pemmaraju, N, Montalban Bravo, G, Loghavi, S, Jelloul, FZ, Wang, W, Wang, S, Muzzafar, T, Patel, KP, Bueso-Ramos, CE, Medeiros, LJ, Kanagal Shamanna, R. Diagnostic challenges of high-grade myeloid malignancies with partial plasmacytoid dendritic cell differentiation. Leukemia and Lymphoma 66(4):764-772, 2025. e-Pub 2025. PMID: 39704386.
9. Nahmod KA, Miranda R, Vega F, Thakral B, Pemmaraju N, Montalban-Bravo G, Loghavi S, Jelloul FZ, Wang W, Wang S, Muzzafar T, Patel K, Bueso-Ramos C, Medeiros LJ, Kanagal-Shamanna R. Diagnostic challenges of high-grade myeloid malignancies with partial plasmacytoid dendritic cell differentiation: report of two cases with literature review. Leukemia & Lymphoma. e-Pub 2024.
10. George GV, Adlowitz DG, Okeson KR, Jelloul FZ, Fang H, Wang W, O'Malley DP, Medeiros LJ, El Hussein S. Cyclin-D1 rearrangement as a secondary event in the large cell transformation of splenic marginal zone lymphoma with a TP53 deletion. Virchows Arch 487(5):1167-1171, 2024. e-Pub 2024. PMID: 39432092.
11. El Hussein S, Fang H, Jelloul FZ, Wang W, Loghavi S, Miranda RN, Friedberg JW, Burack WR, Evans AG, Xu J, Medeiros LJ. T-Cell-Rich Hodgkin Lymphoma With Features of Classic Hodgkin Lymphoma and Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Borderline Category With Overlapping Morphologic and Immunophenotypic Features. Arch Pathol Lab Med 148(8):914-920, 2024. e-Pub 2024. PMID: 38059511.
12. Fang H, Wang SA, Beird HC, Tang Z, You MJ, Li S, Xu J, Hu S, Yin CC, El Hussein S, Lin P, Jelloul FZ, Vega F, Medeiros LJ, Wang W. Morphology, immunophenotype, and suggested diagnostic criteria of TCL1 family-negative T-prolymphocytic leukemia. Am J Clin Pathol, 2024. e-Pub 2024. PMID: 38946194.
13. Jain P, Jelloul FZ. Biclonal mantle cell lymphoma. Blood 143(21):2217, 2024. e-Pub 2024. PMID: 38780924.
14. Root JL, Desai PN, Ly C, Wang B, Jelloul FZ, Zhou J, Mackay S, Alfayez M, Matthews J, Pierce S, Reville PK, Daver N, Abbas HA. Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy. Cancer Res Commun 4(3):671-681, 2024. e-Pub 2024. PMID: 38391202.
15. Wang B, Reville PK, Yassouf MY, Jelloul FZ, Ly C, Desai PN, Wang Z, Borges P, Veletic I, Dasdemir E, Burks JK, Tang G, Guo S, Garza AI, Nasnas C, Vaughn NR, Baran N, Deng Q, Matthews J, Gunaratne PH, Antunes DA, Ekmekcioglu S, Sasaki K, Garcia MB, Cuglievan B, Hao D, Daver N, Green MR, Konopleva M, Futreal A, Post SM, Abbas HA. Comprehensive characterization of IFNgamma signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies. Nat Commun 15(1):1821, 2024. e-Pub 2024. PMID: 38418901.
16. Fan H, Wang F, Zeng A, Murison A, Tomczak K, Hao D, Jelloul FZ, Wang B, Barrodia P, Liang S, Chen K, Wang L, Zhao Z, Rai K, Jain AK, Dick J, Daver N, Futreal A, Abbas HA. Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance. Commun Biol 6(1):765, 2023. e-Pub 2023. PMID: 37479893.
17. Li N, Lin P, Zuo Z, You MJ, Shuai W, Orlowski R, Manasanch EE, Li S, Xu J, Garces S, Jelloul FZ, Tang Z, Wang W, Medeiros LJ, Yin CC. Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis. Cancer Med 12(13):14293-14304, 2023. e-Pub 2023. PMID: 37212518.
18. Desai PN, Wang B, Fonseca A, Borges P, Jelloul FZ, Reville PK, Lee E, Ly C, Basi A, Root J, Baran N, Post SM, Deng Q, Sun H, Harmanci AO, Burks JK, Gomez JA, DiNardo CD, Daver NG, Alatrash G, Konopleva M, Green MR, Antunes DA, Futreal A, Hao D, Abbas HA. Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion. Cancer Immunol Res:OF1-OF18, 2023. e-Pub 2023. PMID: 37285177.
19. Jelloul FZ, Quesada AE, Yang RK, Li S, Wang W, Xu J, Tang G, Yin CC, Fang H, El Hussein S, Khoury J, Bassett RL, Garcia-Manero G, Manasanch EE, Orlowski RZ, Qazilbash MH, Patel KP, Medeiros LJ, Lin P. Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Patients with Myeloma in the Era of Novel Therapies. Mod Pathol 36(6):100166, 2023. e-Pub 2023. PMID: 36990279.
20. El Hussein S, Medeiros LJ, Gruschkus SK, Wei P, Schlette E, Fang H, Jelloul FZ, Wang W, Fiskus W, Kanagal-Shamanna R, Loghavi S, Yang H, Li S, Xu J, Tang Z, Thakral B, Jain N, Wierda WG, Patel K, Bhalla KN, Khoury JD. Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variant. Virchows Arch 482(6):1011-1019, 2023. e-Pub 2023. PMID: 36864257.
21. El Hussein S, Medeiros LJ, Lyapichev KA, Fang H, Jelloul FZ, Fiskus W, Chen J, Wei P, Schlette E, Xu J, Li S, Kanagal-Shamanna R, Yang H, Tang Z, Thakral B, Loghavi S, Jain N, Thompson PA, Ferrajoli A, Wierda WG, Jabbour E, Patel KP, Dabaja BS, Bhalla KN, Khoury JD. Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma. Pathology 55(4):514-524, 2023. e-Pub 2023. PMID: 36933995.
22. Desai PN, Wang B, Fonseca A, Borges P, Jelloul FZ, Reville PK, Lee E, Ly C, Basi A, Root J, Baran N, Post SM, Deng Q, Sun H, Harmanci AO, Burks JK, Gomez JA, DiNardo CD, Daver NG, Alatrash G, Konopleva M, Green MR, Antunes DA, Futreal A, Hao D, Abbas HA. Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion. Cancer Immunol Res 11(7):1011-1028, 2023. e-Pub 2023. PMID: 37163233.
23. Shuai W, Zuo Z, Li N, Garces S, Jelloul FZ, Ok CY, Li S, Xu J, You MJ, Wang W, Rehder C, Jabbour EJ, Patel KP, Medeiros LJ, Yin CC. ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia. Cancer 129(6):878-889, 2023. e-Pub 2023. PMID: 36583229.
24. Desai P, Wang B, Fonseca A, Borges P, FZ J, Reville P, Lee E, Baran N, Post S, Deng Q, Sun H, Harmanci A, Burks J, Gomez J, DiNardo C, Daver N, Al-Atrash G, Konopleva M, Green M, Antunes D, Futreal A, Hao D, Abbas H. Single-cell Profiling of CD8 T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Clonal Hyperexpansion and Dysfunction. Cancer Immunol Res, 2023. e-Pub 2023.
25. Zuo Z, Medeiros LJ, Garces S, Routbort MJ, Ok CY, Loghavi S, Kanagal-Shamanna R, Jelloul FZ, Garcia-Manero G, Chien KS, Patel KP, Luthra R, Yin CC. Concurrent Mutations in SF3B1 and PHF6 in Myeloid Neoplasms. Biology (Basel) 12(1), 2022. e-Pub 2022. PMID: 36671709.
26. Garces S, Rudzki Z, Yin CC, Miranda RN, Medina AM, Sriganeshan V, b C, Li S, Xu J, Jelloul FZ, Khoury JD, Thakral B, Tang B, Tang G, Garces JC, Medeiros LJ. MUM1/IRF4 is Highly Expressed in Dermatopathic Lymphadenopathy: Potential Utility in Diagnosis and Differential Diagnosis. American Journal of Surgical Pathology 46(11):1514-1523, 2022. e-Pub 2022. PMID: 35877199.
27. El Hussein S, Wang X, Fang H, Jelloul FZ, Wang W, Loghavi S, Vega F, Miranda RN, Muzzafar T, Manning JT Jr, Khoury JD, Burack WR, Evans AG, Medeiros LJ. Nodular Lymphocyte-predominant Hodgkin Lymphoma With Nodular Sclerosis: An Underrecognized Feature Associated With Pattern D. Am J Surg Pathol 46(9):1291-1297, 2022. e-Pub 2022. PMID: 35575765.
28. El Hussein S, Yabe M, Wang W, Pemmaraju N, Loghavi S, Jelloul FZ, Fang H, Medeiros LJ, Burack WR, Evans AG, Liesveld JL, Bennett JM. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasms. EJHaem 3(3):954-957, 2022. e-Pub 2022. PMID: 36051075.
29. Fang H, Toruner GA, Tang Z, Tang G, Weissferdt A, Tashakori M, El Hussein S, Thakral B, Quesada AE, Wang W, Patel KP, Garcia-Manero G, Medeiros LJ, Bueso-Ramos CE, Jelloul FZ. Primary mediastinal germ cell tumor and clonally related and unique hematologic neoplasms with i(12p) and TP53 mutation: A report of two cases. Ann Diagn Pathol 59:151951, 2022. e-Pub 2022. PMID: 35489185.
30. Fang H, Wang SA, Hu S, Konoplev SN, Mo H, Liu W, Zuo Z, Xu J, Jorgensen JL, Yin CC, El Hussein S, Jelloul FZ, Tang Z, Medeiros LJ, Wang W. Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometry. Cytometry B Clin Cytom 102(4):283-291, 2022. e-Pub 2022. PMID: 35716019.
31. Jelloul FZ, Yang R, Garces S, Kanagal-Shamanna R, Ok CY, Loghavi S, Routbort MJ, Zuo Z, Yin CC, Floyd K, Bassett RL, Wierda W, Jain N, Thompson P, Luthra R, Medeiros LJ, Patel KP. Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia. Leuk Res 116:106827, 2022. e-Pub 2022. PMID: 35430388.
32. Garces S, Medeiros LJ, Marques-Piubelli ML, Coelho Siqueira SA, Miranda RN, Cuglievan B, Sriganeshan V, Medina AM, Garces JC, Saluja K, Bhattacharjee MB, Khoury JD, Li S, Xu J, Jelloul FZ, Thakral B, Cameron Yin C. Cyclin D1 expression in Rosai-Dorfman disease: a near-constant finding that is not invariably associated with mitogen-activated protein kinase/extracellular signal-regulated kinase pathway activation. Hum Pathol 121:36-45, 2022. e-Pub 2022. PMID: 34995673.
33. Bannon SA, Routbort MJ, Montalban-Bravo G, Mehta RS, Jelloul FZ, Takahashi K, Daver N, Oran B, Pemmaraju N, Borthakur G, Naqvi K, Issa G, Sasaki K, Alvarado Y, Kadia TM, Konopleva M, Shamanna RK, Khoury JD, Ravandi F, Champlin R, Kantarjian HM, Bhalla K, Garcia-Manero G, Patel KP, DiNardo CD. Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations. Front Oncol 10:582213, 2021. e-Pub 2021. PMID: 33585199.
34. Lyapichev KA, Jelloul FZ. Simultaneous bone marrow involvement by CLL/SLL and LEF1/cyclin D1-positive metastatic melanoma. Blood 136(2):258, 2020. e-Pub 2020. PMID: 32645172.
35. Liu Y, Jelloul FZ, Zhang Y, Bhavsar T, Ho C, Rao M, Lewis NE, Cimera R, Baik J, Sigler A, Sen F, Yabe M, Roshal M, Landgren O, Dogan A, Xiao W. Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma. Am J Surg Pathol 44(6):838-848, 2020. e-Pub 2020. PMID: 32118627.
36. Yang RK, Qing Y, Jelloul FZ, Routbort MJ, Wang P, Shaw K, Zhang J, Lee J, Medeiros LJ, Kopetz S, Tetzlaff MT, Broaddus RR. Identification of biomarkers of immune checkpoint blockade efficacy in recurrent or refractory solid tumor malignancies. Oncotarget 11(6):600-618, 2020. e-Pub 2020. PMID: 32110280.
37. Steers NJ, Li Y, Drace Z, D'Addario JA, Fischman C, Liu L, Xu K, Na YJ, Neugut YD, Zhang JY, Sterken R, Balderes O, Bradbury D, Ozturk N, Ozay F, Goswami S, Mehl K, Wold J, Jelloul FZ, Rohanizadegan M, Gillies CE, Vasilescu EM, Vlad G, Ko YA, Mohan S, Radhakrishnan J, Cohen DJ, Ratner LE, Scolari F, Susztak K, Sampson MG, Deaglio S, Caliskan Y, Barasch J, Courtney AE, Maxwell AP, McKnight AJ, Ionita-Laza I, Bakker SJL, Snieder H, de Borst MH, D'Agati V, Amoroso A, Gharavi AG, Kiryluk K. Genomic Mismatch at LIMS1 Locus and Kidney Allograft Rejection. N Engl J Med 380(20):1918-1928, 2019. e-Pub 2019. PMID: 31091373.
38. Jelloul FZ, Navarro M, Navale P, Hagan T, Cocker RS, Das K, Rosen L, Zhang X, Sheikh-Fayyaz S. Diagnosis of Lymphoma Using Fine-Needle Aspiration Biopsy and Core-Needle Biopsy: A Single-Institution Experience. Acta Cytol 63(3):198-205, 2019. e-Pub 2019. PMID: 30909285.
39. Jelloul FZ, Chen QH, Yang T, Haghi N, Brody J, Zhang X, Sheikh-Fayyaz S. Composite Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia and Follicular Lymphoma: A Clinicopathological Study of Six Cases. Int J Surg Pathol 26(2):135-144, 2018. e-Pub 2018. PMID: 29069998.
40. Brandler TC, Aziz MS, Coutsouvelis C, Rosen L, Rafael OC, Souza F, Jelloul FZ, Klein MA. Young investigator challenge: Atypia of undetermined significance in thyroid FNA: Standardized terminology without standardized management--a closer look at repeat FNA and quality measures. Cancer Cytopathol 124(1):37-43, 2016. e-Pub 2016. PMID: 26765064.
41. Brandler TC, Jelloul FZ, Soto D, Das K, Rosen L, Bhuiya TA. Young investigator challenge: Cadherin-17 and SATB2 in cytology specimens: Do these new immunostains help in differentiating metastatic colorectal adenocarcinoma from adenocarcinomas of other origins?. Cancer Cytopathol 123(12):706-13, 2015. e-Pub 2015. PMID: 26671737.
42. Ferrante M, Khan A, Fan C, Jelloul FZ. Schwannoma of the cervical esophagus. Rare Tumors 6(2):5361, 2014. e-Pub 2014. PMID: 25002950.

Review Articles

1. Qiu L, Cho JH, Jelloul FZ, Vega F. SOHO State of the Art Updates and Next Questions: Pathology and Pathogenesis of Nodal Peripheral T-Cell Lymphomas. Clin Lymphoma Myeloma Leuk 22(5):287-296, 2022. e-Pub 2022. PMID: 34776400.

Abstracts

1. Nirmalanantham, P, Quesada, AE, Ghosh, A, Lin, P, Ok, CY, Yang, RK, Fang, H, Garces, S, Kanagal Shamanna, R, Loghavi, S, Routbort, MJ, Yin, CC, Wei, W, Pasyar, S, Bassett Jr, R, El Hussein, S, Jain, N, Burger, JA, Wierda, WG, Wang, S, Bueso-Ramos, CE, Patel, KP, Medeiros, LJ, Jelloul, FZ. Mutational Landscape and Clinical Impact of SPEN Mutations in Patients with Chronic Lymphocytic Leukemia. Cancers 17(21), 2025. e-Pub 2025. PMID: 41228377.
2. Chen Y, Bi T, Xu M, Lee J, Lu W, Zhuang M, Velarde AM, Yang H, Alatrash G, Rondon G, Shpall E, Jelloul F, Cervoni-Curet F, Kerros C, Koppikar P, Molldrem J, Garcia-Manero G, Patel A, Bachireddy P. Myelodysplastic Syndromes: Basic and Translational. The 67th ASH Annual Meeting Abstracts, 2025. e-Pub 2025.
3. Rodriguez-Sevilla JJ, Chien K, Li Z, Jelloul F, Li R, Ali NA, Sallman D, Kanagal-Shamanna R, Csizmar C, Mangaonkar A, Patnaik M, Jerez A, Montoro MJ, Valcarcel D, Castaño-Díez S, Díaz-Beyá M, Esteve J, Rey MD, Diez-Campelo M, Calvo X, Sole F, Montalban-Bravo G, Padron E, Garcia-Manero G, Komrokji R. Myelodysplastic Syndromes: Clinical and Epidemiological. The 67th ASH Annual Meeting Abstracts, 2025.
4. Arora S, Jen W, Bazinet A, Maiti A, Issa G, Kadia T, Borthakur G, Ravandi F, Valero YA, Yilmaz M, Ok CY, Fang H, Quesada A, Kanagal-Shamanna R, Jelloul F, Patel K, Medeiros L, Kantarjian H, Daver N, DiNardo C, Loghavi S. Acute Myeloid Leukemias: Clinical and Epidemiological. The 67th ASH Annual Meeting Abstracts, 2025. e-Pub 2025.
5. Ebsworth T, Ruane S, Bhardwaj N, Cooper R, Green A, Hay D, Ihlow J, Jelloul F, Kanagal-Shamanna R, Macklin P, Manohar V, Olmeda E, Ong M, Pescia C, Quesada A, Bashir S, Maxwell S, Sirinukunwattana K, Aberdeen A, Rittscher J, Royston D. Emerging Tools, Techniques, and Artificial Intelligence in Hematology. American Society of Hematology, 2025. e-Pub 2025.
6. El Hussein S, Adlowitz DG, Syposs R, Elsadawi M, Fang H, Jelloul FZ, Loghavi S, Wang W, Medeiros LJ. STAT6 Mutational Status in Primary Mediastinal B-Cell Lymphoma with STAT6 Nuclear or Cytoplasmic Expression by Immunohistochemistry. United States and Canadian Academy of Pathology, 2023. e-Pub 2023.
7. Hwan KD, Jelloul FZ, Longhavi S, Kanagal-Shamanna R, Yin CC, Zuo Z, Patel KP, Rout. Next-Generation Sequencing Identifies Approximately One Third of Mantle Cell Lymphoma Patients with Nuclear factor-kappa B Pathway Mutations. United States and Canadian Academy of Pathology, 2023. e-Pub 2023.
8. Liu M, Wang X, Shuyu E, Tang G, Wang W, Jelloul FZ, Lin P, Medeiros LJ, Hu S. Myeloid Neoplasms with t(2;3)(p23~23;3q26.2): a Report of 21 Cases. United States and Canadian Academy of Pathology, 2023. e-Pub 2023.
9. Jain P, Chi CO, Fetooh A, Kanagal-Shamanna R, Jelloul FZ, Hill H, Floyd K, Longhavi S, Zuo Z, Yin CC, Routbort M, Tang G, Ahmed S, Malpica Castillo LE, Siddiqui A, Chen W, Oriabure O, Badillo M, Steiner RE, lyer SP, Lee HJ, Luthra R, Vega-Vazquez F, Flowers CR, Medeiros LJ, Wang ML, Patel KP, Fowler NH, Nair R. Mutation Spectrum, Characteristics and Impact of Mutation Profiling on Prognosis, Outcome and Treatment responses in Patients (pts) with Mantle Cell Lymphoma. American Society of Hematology, 2022. e-Pub 2022.
10. Huarte EA, Jabbour E, Konopleva M, Nunez C, Konoplev S, Short N, Pemmaraju N, Jelloul FZ, Tang G, Kantarjian H, Jain N. Outcomes of PAtients with B-ALL with Concomitant BCR::ABL1 and CRLF2 Rearrangements. American Society of Hematology, 2022. e-Pub 2022.
11. Wang B, Jelloul FZ, Borges P, Desai P, Guillin Tang G, Konopleva M, Baran N, Green MR, Deng Q, Daver N, Futreal A, Hao D, Abbas HA. Single Cell RNA-Seq Reveals Intra-Tumoral Heterogeneity Relevant to Differentiation States and Outcomes Among Newly Diagnosed Acute Myeloid Leukemia Patients. American Society of Hematology, 2022. e-Pub 2022.
12. Desai P, Wang B, Jelloul FZ, Alatrash G, Baran N, Deng Q, Green MR, Daver N, Konopleva M, Futreal A, Hao D, Abbas HA. Single-Cell Profiling of CD8 Landscape in Treatment Naïve and Relapsed/Refractory AML Patients Reveals Distinct Effector Cellular States Predictive of Outcomes. American Society of Hematology, 2022. e-Pub 2022.
13. Kern W, Tembhare PR, Nejati R, Jelloul FZ, Walter W, Joseph D Khoury JD, Haferlach T. Identification of Phenotypic Subgroups of Acute Myeloid Leukemia Defined By Differentiation According to WHO 2022 Classification. American Society of Hematology, 2022. e-Pub 2022.
14. Venugopal S, Loghavi S, Routbort M, Jelloul FZ, Kanagal-Shamanna R, Pierce SA, Issa GC, Abbas HA, Sasaki K, Takahashi K, Daver N, Ravandi F, Kantarjian H, DiNardo CD. Clinical and Molecular Characteristics of Newly Diagnosed IDH/TP53 Co-Mutated AML and Impact of Genomically Sensitive Treatment Strategies. American Society of Hematology, 2022. e-Pub 2022.
15. Fang H, Wang S, Khoury J, El Hussein S, Kim DH, Tashakori M, Tang Z, Li S, Hu Z, Jelloul FZ, Patel KP, McDonnell TJ, Medeiros LJ, W: W. The molecular and Immunophenotypic Features of Pure Erythroid Leukemia. United States and Canadian Academy of Pathology, 2022. e-Pub 2022.
16. Fang H, Wang S, El Hussein S, Konoplev SN, Mo H, Liu W, Zuo Z, Hu S, Jelloul FZ, Tang Z, Medeiros LJ, W: W. Acute Promyelocytic Leukemia: its Immunophenotype and Differential Diagnosis. United States and Canadian Academy of Pathology, 2022. e-Pub 2022.
17. Jelloul FZ, Yang RK, Li S, Tang G, Patel KP, Medeiros LJ, P: L. Clinicopathologic Features of Therapy -Related Myeloid Neoplasms in Myeloma Patients in The Era of Novel Therapies: A study of 60 Patients. United States and Canadian Academy of Pathology, 2021. e-Pub 2021.
18. Yang RK, Routbort M, Wang P, Jelloul FZ, Patel KP, Luthra R, Broaddus RR. Context-Dependent Impact of Tumor Mutation Burden on Overall Survival in Patients with Advanced Cancers Resistant to Front-Line Therapy. United States and Canadian Academy of Pathology, 2019. e-Pub 2019.
19. Jelloul FZ, Pichardo J D, Khattar P, Rao M, Areeyqur R, Jungbluth A, Wang L, Zhang Y, Dogan A. MHC Class II Transactivator (CIITA) Abnormalities Are Frequent in B-cell Lineage Lymphomas and Are Associated With Loss of MHC Class II (MHCII) Expression. United States and Canadian Academy of Pathology, Annual Meeting, 2018. e-Pub 2018.
20. Khattar P, Pichardo J D, Jelloul FZ, Robert C, Areeyqur R, Rao M, Zhang Y, Arcila M, Wang L, A: D. t(14;18) Negative Inguinal Follicular Lymphoma Is Characterized By Genetic Abnormalities of 1p36/TNFRSF14 and 16p/CREBBP Regions. Unites States and Canadian Academy of Pathology Annual Meeting, 2018. e-Pub 2018.
21. Jelloul FZ, Bhavsar T, Pichardo J D, Yabe M, Rao M, Zhang Y, Dogan A, Xiao W. Extramedullary Plasmablastic Transformation of Plasma Cell Myeloma: Clinicopathologic Study of 10 cases. United States and Canadian Academy of Pathology, Annual Meeting, 2018. e-Pub 2018.
22. Jelloul FZ, Auguste L J, Palsana D H, Bhuiya T, Esposito M J. Validation of the Mobile Whole Slide Imaging as a Low Resource Acquisition and Transport Technique for Microscopic Pathological Specimens. United States and Canada Academy of Pathology, 2016. e-Pub 2016.
23. Guo H, Hsu P, Jelloul FZ, Lee P, Brody J, Sheikh-Fayyaz S, Zhang X. Expression of a Long Non-Coding RNA GATA3 AS-1 in Peripheral T-Cell Lymphoma (PTCL). United States and Canadian Academy of Pathology, 2016. e-Pub 2016.
24. Jelloul FZ, Aziz MS, Kahn L, Breur F, Brandler TC. Clear Cell Chondrosarcoma; A Rare Tumor- Even Rarer On Cytology Preparations: Case Report And Review Of The Literature. College of American Pathologists, Annual Meeting, 2015. e-Pub 2015.
25. Jelloul FZ, Chen Q H, Yang T, Brody J, Zhang X, Sheikh-Hayyaz S. Composite chronic lymphocytic Leukemia/small lymphocytic lymphoma and follicular lymphoma. American Society of Clinical Pathology, Annual Meeting, 2015. e-Pub 2015.
26. Ronaghy A, Jelloul FZ, Yang T, Brody J, Navarro M, Zhang X, Sheikh-Fayyaz S. Kaposi sarcoma associated herpesvirus-and Epstein-Barr virus associated germinotropic lymphoproliferative disorder presents a solitary retroperitoneal mass. American Society of Clinical Pathology, Annual Meeting, 2015. e-Pub 2015.
27. Jelloul FZ, Sheikh-Fayyaz S, Vitkovski T, Zhang X, Hsu P. Primary Nodular Lymphocyte Predominat Hodgkin Lymphoma of the small bowel. College of American Pathologists, Annual Meeting, 2015. e-Pub 2015.
28. Shah P, Moreira DM, George AK, Nikhil Waingankar MA, Sohval S, Jelloul FZ, Yaskiv O, Schwartz MJ, Vira MA, Steckel J, Richstone L, Kavoussi LR. Prognostic Stratification of Pathologic Stage T3a Renal Cell Carcinoma After Radical Nephrectomy. American Urological association Annual meeting;, 2015. e-Pub 2015.
29. Jelloul FZ, Guo H, Hsu P, Brody J, Sheikh-Fayyaz S, Zhang X. Evaluation of GATA-3 expression in T cell lymphoma. Unites States and Canadian Academy of Pathology, 2015. e-Pub 2015.
30. Brandler TC, Jelloul FZ, Das K, Soto D, Bhuiya T. SATB2 and Cadherin-17 in Cytology Specimens: Do These New Immunostains Help in Differentiating Metastatic Colorectal Adenocarcinoma From Adenocarcinomas of Other Origins?. United States and Canadian Academy of Pathology, 2015. e-Pub 2015.
31. Jelloul FZ, Navarro N, Navale P, Hagan T, Zhang X, Sheikh-Fayyaz S. Utility of Fine Needle Aspiration and Core Needle Biopsy in the diagnosis and Classification of Lymphoma: A Single Institution Experience. United States and Canada Academy of Pathology, 2015. e-Pub 2015.
32. Jelloul FZ, Chen Q H, Yang T, Brody J, Zhang X, Sheikh-Fayyaz S. Composite chronic lymphocytic leukemia/small lymphocytic lymphoma and follicular lymphoma. American Society of Clinical Pathology, Annual Meeting, 2015. e-Pub 2015.
33. Jelloul FZ, Mirzamani N, Brandler TC, Bhuiya TA, Das K, Alexis C, Yaskiv O. Primary Thyroid-like Follicular Renal Cell Carcinoma: Case Report Of An Emerging Entity and Review of The Literature. College of American Pathologists, Annual Meeting, 2014. e-Pub 2014.
34. Jelloul FZ, Carreon CK, Zhang X, Sheikh-Fayyaz S. CD 5 Positive Intravascular Large B Cell Lymphoma In A Patient With Wilson Disease. College of American Pathologists, Annual Meeting, 2014. e-Pub 2014.
35. Jelloul FZ, Gordin S, Reder I, Aziz MS. Microcystic Adnexal Carcinoma; Case Report Of A Rare Tumor And Review Of The Literature. College of American Pathologists, Annual Meeting, 2014. e-Pub 2014.
36. Jelloul FZ, Vitkovski T, Chowdhury M, Aziz MS. Pseudomyxoma Peritonei: Secondary To Appendiceal Tumor Or To A Synchronous Tumor In Appendix And Ovary? Case Presentation And Review Of Literature. College of American Pathologists, Annual Meeting, 2014. e-Pub 2014.
37. Chen Y, Bi T, Xu M, Lee J, Lu WS, Zhuang M, Velarde AM, McCurry D, Yang H, Al-Atrash G, Rondon G, Shpall E, Jelloul FZ, Cervoni-Curet FN, Ghanem S, Kerros C, Koppikar P, Molldrem J, Garcia-Manero G, Patel A, Bachireddy P. Molecular and cellular dynamics of measurable residual disease progression in myelodysplastic syndromes. PMID: 41279348.
38. Jain P, Hill HA, Ok CY, Nesmalov A, Segodin V, Tabakov D, Kotlov N, Zemskiy P, Belykh E, Nomie K, Fetooh A, Kanagal-Shamanna R, Jelloul FZ, Tang G, Vega F, Fowler N, Flowers CR, L Wang AM. Genomic and Transcriptomic Profiles of Blastoid and Pleomorphic Mantle Cell Lymphoma Are Distinct from Classic Histology Mantle Cell Lymphoma. ASH Annual Meeting & Exposition.
39. Wang B, Reville PK, Jelloul FZ, Desai P, Borges P, Ly C, Veletic I, Dasdemir E, Burks JK, Tang G, Guo S, Vaugh N, Baran N, Deng Q, Matthews J, Gunaratne P, Antunes DA, Ekmekcioglu S, Sasaki K, Garcia MB, Cuglievan B, Hao D, Daver N, Green MR, Konopleva M, Futreal A, Post SM, IFNγ AH. Signaling in Acute Myeloid Leukemia Mediates Immunomodulation and Reveals Therapeutic Strategies. American Society of Hematology.
40. Wang B, Ly C, Dasdemir E, Jelloul FZ, Desai P, Borges P, Root JL, Tang G, Gunaratne P, Basu S, Jindal S, Chen Y, Wani KM, Lazar AJ, Sharma P, Reville PK, Abbas HA. Characterizing Inferred Functional and Phenotypical States of Newly Diagnosed Acute Myeloid Leukemia from Single Cell Transcriptomic Profiling. American Society of Hematology.
41. Jessica LR, Desai P, Borges P, Reville PK, Ly C, Wang, B, Jelloul FZ, Zhou J, Mackay SG, Alfayez M, Matthews J, Pierce S, Daver N, Abbas HA. Single-Cell Polyfunctional Proteomic Profiling Reveals Temporal and Niche Differences in CD4 and CD8 T-cells in Acute Myeloid Leukemia Following PD-1 Blockade Therapy. American Society of Hematology.
42. Jain P, Chi Young OK, Nastoupil LJ, Westin J, Hill HA, Nair R, Iyer SP, Fetooh A, Lee HJ, Ahmed S, Kanagal-Shamanna R, Jelloul FZ, Malpica Castillo LE, Liu Y, Li Y, Vargas J, Feng L, Badillo M, Thirumurthi S, Xu G, Deswal A, Iliescu C, Nguyen VQ, Tang G, Patel KP, Vega F, Medeiros L, Wang ML, R Flowers AC. Acalabrutinib with Rituximab As First-Line Therapy for Older Patients with Mantle Cell Lymphoma – a Phase II Clinical Trial. ASH Annual Meeting & Exposition.
43. Parisi X, Wang W, Liu W, Loghavi S, Hu S, Jelloul FZ, Medeiros LJ, Hong F. Reactive Intra-sinusoidal Immunoblastic Proliferations In Lymph Nodes: A Diagnostic Pitfall for Diffuse Large B-Cell Lymphoma. United States and Canadian Academy of Pathology.
44. Jelloul FZ, Shuai W, Yang RK, Fang H, Patel KP, Medeiros LJ, Lin P. Clinicopathologic Features of 73 Patients with TP53 Mutated Multiple Myeloma. International Myeloma Society annual meeting.
45. Shuyu E, Jelloul FZ, Nahmod A, Leventaki V, Medeiros LJ, Wang SA. Acute Lymphoblastic Leukemia with T and B-Markers, a Perplexing Lineage Origin?. European Association for Haematopathology-Society of Hematopathology meeting.
46. Yang RK, Routbort M, Wang P, Jelloul FZ, Patel KP, Luthra R, Broaddus RR. Context-Dependent Impact of Tumor Mutation Burden on Overall Survival in Patients with Advanced Cancers Resistant to Front-Line Therapy. United States and Canadian Academy of Pathology.
47. Jelloul FZ, Floyd K, San Lucas FA, Lohman EJ, Medeiros LJ, Luthra R, Patel KP. Antigen Receptor Stereotypy in Chronic Lymphocytic Leukemia. Association of Molecular Pathology.
48. Jelloul FZ, Yang R, Wang P, Kanagal R, Ok CY, Loghavi S, Routbort MJ, Zuo Z, Yin CC, Floyd K, Wierda W, Luthra R, Medeiros LJ, Patel KP. Non-coding NOTCH1 mutations in chronic lymphocytic leukemia. Association of Molecular Pathology, Annual Meeting,.

Letters to the Editor

1. Zhou T, Curry CV, Khanlari M, Shi M, Cui W, Peker D, Chen W, Wang E, Gao J, Shen Q, Xie W, Jelloul FZ, King RL, Yuan J, Wang X, Zhao C, Obiorah IE, Courville EL, Nomura E, Cherian S, Xu ML, Burack WR, Liu HX, Jabbour EJ, Takahashi K, Wang W, Wang SA, Khoury JD, Medeiros LJ, Hu S. Genetics and pathologic landscape of lineage switch of acute leukemia during therapy. Blood Cancer J 14: 19, 2024.
2. Jelloul FZ, Routbort MJ, DiNardo CD, Bueso-Ramos CE, Kanagal-Shamanna R, Thakral B, Zuo Z, Yin CC, Loghavi S, Ok CY, Wang SA, Tang Z, You MJ, Patel KP, Medeiros LJ, Quesada AE. DDX41 mutations in patients with non-myeloid hematologic neoplasms. Am J Hematol 98: E193-E196, 2023.
3. Fang H, Wang SA, Khoury JD, El Hussein S, Kim DH, Tashakori M, Tang Z, Li S, Hu Z, Jelloul FZ, Patel KP, McDonnell TJ, Kadia T, Medeiros LJ, Wang W. Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases. Haematologica 107: 2232-2237, 2022.
4. Jelloul FZ, Yang RK, Wang P, Garces S, Kanagal-Shamanna R, Ok CY, Loghavi S, Routbort MJ, Zuo Z, Yin CC, Floyd K, Bassett RL Jr, Wierda WG, Jain N, Thompson PA, Luthra R, Medeiros LJ, Patel KP. Non-coding NOTCH1 mutations in chronic lymphocytic leukemia negatively impact prognosis. Am J Hematol 97: E100-E102, 2022.
5. El Hussein S, Hu S, Fang H, Garces S, Muzzafar T, Wang SA, Medeiros LJ, Bueso-Ramos C, Jelloul FZ. Well-differentiated systemic mastocytosis with associated myeloid sarcoma and myelodysplastic syndrome: Diagnostic challenges of an underrecognized entity. Leuk Lymphoma 63: 235-238, 2022.